Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aerovate Therapeutics: Q2 Earnings Insights

  Aerovate Therapeutics (NASDAQ:AVTE) reported its Q2 earnings results on Monday, August 15, 2022 at 09:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Aerovate Therapeutics (NASDAQ:AVTE) reported its Q2 earnings results on Monday, August 15, 2022 at 09:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aerovate Therapeutics missed estimated earnings by 8.89%, reporting an EPS of $-0.49 versus an estimate of $-0.45.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.17 which was followed by a 5.6% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aerovate Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Kohl’s Earnings: A Preview

By Benzinga Insights
Today, 2:09 AM
  Kohl's (NYSE:KSS) is set to give its latest quarterly earnings report on Thursday, 2022-08-18. Here's what investors need to know before the announcement. Analysts estimate that Kohl's will report an earnings per share (EPS) of $1.14.

KSS

Read More

Recap: Gevo Q4 Earnings

By Benzinga Insights
Today, 2:09 AM
Gevo (NASDAQ:GEVO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Gevo missed estimated earnings by 14.29%, reporting an EPS of $-0.08 versus an estimate of $-0.07.

GEVO